86 related articles for article (PubMed ID: 8977461)
1. Induction of hepatic uptake of lipoprotein(a) by cholesterol-derivatized cluster galactosides.
Biessen EA; Vietsch H; van Berkel TJ
Arterioscler Thromb Vasc Biol; 1996 Dec; 16(12):1552-8. PubMed ID: 8977461
[TBL] [Abstract][Full Text] [Related]
2. Cholesterol derivative of a new triantennary cluster galactoside directs low- and high-density lipoproteins to the parenchymal liver cell.
Biessen EA; Vietsch H; Van Berkel TJ
Biochem J; 1994 Aug; 302 ( Pt 1)(Pt 1):283-9. PubMed ID: 8068017
[TBL] [Abstract][Full Text] [Related]
3. The cholesterol derivative of a triantennary galactoside with high affinity for hepatic asialoglycoprotein receptor: a potent cholesterol lowering agent.
Biessen EA; Broxterman H; van Boom JH; van Berkel TJ
J Med Chem; 1995 May; 38(11):1846-52. PubMed ID: 7783116
[TBL] [Abstract][Full Text] [Related]
4. Cholesterol derivative of a new triantennary cluster galactoside lowers serum cholesterol levels and enhances secretion of bile acids in the rat.
Biessen EA; Vietsch H; Van Berkel TJ
Circulation; 1995 Mar; 91(6):1847-54. PubMed ID: 7882496
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of cluster galactosides with high affinity for the hepatic asialoglycoprotein receptor.
Biessen EA; Beuting DM; Roelen HC; van de Marel GA; van Boom JH; van Berkel TJ
J Med Chem; 1995 Apr; 38(9):1538-46. PubMed ID: 7739012
[TBL] [Abstract][Full Text] [Related]
6. In vivo fate and scavenger receptor recognition of oxidized lipoprotein[a] isoforms in rats.
de Rijke YB; Jürgens G; Hessels EM; Hermann A; van Berkel TJ
J Lipid Res; 1992 Sep; 33(9):1315-25. PubMed ID: 1328446
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of novel amphiphilic dendritic galactosides for selective targeting of liposomes to the hepatic asialoglycoprotein receptor.
Sliedregt LA; Rensen PC; Rump ET; van Santbrink PJ; Bijsterbosch MK; Valentijn AR; van der Marel GA; van Boom JH; van Berkel TJ; Biessen EA
J Med Chem; 1999 Feb; 42(4):609-18. PubMed ID: 10052968
[TBL] [Abstract][Full Text] [Related]
8. Specific targeting of the antiviral drug 5-iodo 2'-deoxyuridine to the parenchymal liver cell using lactosylated poly-L-lysine.
Biessen EA; Beuting DM; Vietsch H; Bijsterbosch MK; Van Berkel TJ
J Hepatol; 1994 Nov; 21(5):806-15. PubMed ID: 7890898
[TBL] [Abstract][Full Text] [Related]
9. In vivo studies on the binding sites for lipoprotein (a) on parenchymal and non-parenchymal rat liver cells.
Harkes L; Jürgens G; Holasek A; van Berkel TJ
FEBS Lett; 1988 Jan; 227(1):27-31. PubMed ID: 2828109
[TBL] [Abstract][Full Text] [Related]
10. Role of lipoprotein-X in the pathogenesis of cholestatic hypercholesterolemia. Uptake of lipoprotein-X and its effect on 3-hydroxy-3-methylglutaryl coenzyme A reductase and chylomicron remnant removal in human fibroblasts, lymphocytes, and in the rat.
Walli AK; Seidel D
J Clin Invest; 1984 Sep; 74(3):867-79. PubMed ID: 6470142
[TBL] [Abstract][Full Text] [Related]
11. Evidence of dependence of lipoprotein(a) on triglyceride and high-density lipoprotein metabolism.
Konerman M; Kulkarni K; Toth PP; Jones SR
J Clin Lipidol; 2012; 6(1):27-32. PubMed ID: 22264571
[TBL] [Abstract][Full Text] [Related]
12. Uptake of lactosylated low-density lipoprotein by galactose-specific receptors in rat liver.
Bijsterbosch MK; Van Berkel TJ
Biochem J; 1990 Aug; 270(1):233-9. PubMed ID: 1697748
[TBL] [Abstract][Full Text] [Related]
13. Galactose-specific asialoglycoprotein receptor is involved in lipoprotein (a) catabolism.
Hrzenjak A; Frank S; Wo X; Zhou Y; Van Berkel T; Kostner GM
Biochem J; 2003 Dec; 376(Pt 3):765-71. PubMed ID: 14510638
[TBL] [Abstract][Full Text] [Related]
14. Lactosylated high density lipoprotein: a potential carrier for the site-specific delivery of drugs to parenchymal liver cells.
Bijsterbosch MK; Van Berkel TJ
Mol Pharmacol; 1992 Feb; 41(2):404-11. PubMed ID: 1311413
[TBL] [Abstract][Full Text] [Related]
15. Development of lipoprotein-like lipid particles for drug targeting: neo-high density lipoproteins.
Schouten D; van der Kooij M; Muller J; Pieters MN; Bijsterbosch MK; van Berkel TJ
Mol Pharmacol; 1993 Aug; 44(2):486-92. PubMed ID: 8355672
[TBL] [Abstract][Full Text] [Related]
16. Lactosylated low density lipoprotein: a potential carrier for the site-specific delivery of drugs to Kupffer cells.
Bijsterbosch MK; Ziere GJ; Van Berkel TJ
Mol Pharmacol; 1989 Sep; 36(3):484-9. PubMed ID: 2550781
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
Attman PO; Samuelsson OG; Moberly J; Johansson AC; Ljungman S; Weiss LG; Knight-Gibson C; Alaupovic P
Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
[TBL] [Abstract][Full Text] [Related]
18. The role of the low-density lipoprotein receptor-related protein (LRP) in the plasma clearance and liver uptake of recombinant single-chain urokinase-type plasminogen activator in rats.
van der Kaaden ME; Rijken DC; Kruijt JK; van Berkel TJ; Kuiper J
Thromb Haemost; 1997 Apr; 77(4):710-7. PubMed ID: 9134648
[TBL] [Abstract][Full Text] [Related]
19. Enhanced macrophage uptake of lipoprotein(a) after Ca2+-induced aggregate-formation.
Tanaka S; Yashiro A; Tasaki H; Nakashima Y
Lipids; 1998 Apr; 33(4):385-92. PubMed ID: 9590626
[TBL] [Abstract][Full Text] [Related]
20. Influence of atorvastatin on fractional and subfractional composition of serum lipoproteins and MMP activity in mice with Triton WR 1339-induced lipaemia.
Korolenko TA; Cherkanova MS; Tuzikov FV; Johnston TP; Tuzikova NA; Loginova VM; Kaledin VI
J Pharm Pharmacol; 2011 Jun; 63(6):833-9. PubMed ID: 21585382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
